Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in San Diego, California and Jupiter, Florida.

Biotechnology

Expansion Therapeutics

Renato Skerlj

Ln Vogeti

Imelda Sollomoni

Alicia Angelbello

Nicole Delorenzo

Michelle House

Treleasha Simmons

Sandra Mueller

Van Ha

Kamalakannan Vishnu

Michelle Arsenault

Sai Velagadupi

Helen Crehan

Daniela Saldias

Jared Baisden

Jason Ilardo

Kamal Vishnu

Jennifer Visco

Tiviane Vu

Peter Connolly

Mark Ledeboer

The Scientific Team at Expansion Therapeutics focuses on the discovery and development of small molecule medicines targeting RNA-mediated diseases. This team conducts cutting-edge research to identify potent and specific small molecule binders of RNA using the company's proprietary technologies. Their work includes exploring RNA targets, validating biological assays, and advancing promising drug candidates through the preclinical development pipeline, with an initial emphasis on expansion repeat diseases.

Scientific Team

Research and Development

Scientific Advisory Team

Scientific Team

About

Team members

Other teams at Expansion Therapeutics

Research and Development

Scientific Advisory Team